Kalaris Therapeutics Stock Forward View - Accumulation Distribution
| KLRS Stock | 9.14 0.50 5.19% |
Kalaris Stock outlook is based on your current time horizon.
At this time the rsi of Kalaris Therapeutics' share price is below 20 . This indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Current Year (3.70) | EPS Estimate Next Year (2.38) | Wall Street Target Price 19.6667 | EPS Estimate Current Quarter (1.16) |
Using Kalaris Therapeutics hype-based prediction, you can estimate the value of Kalaris Therapeutics from the perspective of Kalaris Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Kalaris Therapeutics after-hype prediction price | USD 8.2 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Kalaris Therapeutics to cross-verify your projections. Kalaris Therapeutics Additional Predictive Modules
Most predictive techniques to examine Kalaris price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Kalaris using various technical indicators. When you analyze Kalaris charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check Kalaris Therapeutics Volatility | Backtest Kalaris Therapeutics | Information Ratio |
Kalaris Therapeutics Trading Date Momentum
| On February 12 2026 Kalaris Therapeutics was traded for 9.14 at the closing time. The top price for the day was 9.14 and the lowest listed price was 9.14 . There was no trading activity during the period 0.0. Lack of trading volume on February 12, 2026 did not cause price change. The trading delta at closing time against the current closing price is 5.47% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Kalaris Therapeutics to competition |
Other Forecasting Options for Kalaris Therapeutics
For every potential investor in Kalaris, whether a beginner or expert, Kalaris Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Kalaris Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Kalaris. Basic forecasting techniques help filter out the noise by identifying Kalaris Therapeutics' price trends.Kalaris Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Kalaris Therapeutics stock to make a market-neutral strategy. Peer analysis of Kalaris Therapeutics could also be used in its relative valuation, which is a method of valuing Kalaris Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Kalaris Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Kalaris Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Kalaris Therapeutics shares will generate the highest return on investment. By undertsting and applying Kalaris Therapeutics stock market strength indicators, traders can identify Kalaris Therapeutics entry and exit signals to maximize returns.
| Rate Of Daily Change | 0.95 | |||
| Day Median Price | 9.14 | |||
| Day Typical Price | 9.14 | |||
| Price Action Indicator | (0.25) | |||
| Period Momentum Indicator | (0.50) |
Kalaris Therapeutics Risk Indicators
The analysis of Kalaris Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Kalaris Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting kalaris stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.78 | |||
| Semi Deviation | 4.12 | |||
| Standard Deviation | 6.6 | |||
| Variance | 43.58 | |||
| Downside Variance | 26.63 | |||
| Semi Variance | 17.0 | |||
| Expected Short fall | (5.75) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Kalaris Therapeutics
The number of cover stories for Kalaris Therapeutics depends on current market conditions and Kalaris Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Kalaris Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Kalaris Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Kalaris Therapeutics Short Properties
Kalaris Therapeutics' future price predictability will typically decrease when Kalaris Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Kalaris Therapeutics often depends not only on the future outlook of the potential Kalaris Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Kalaris Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 5 M | |
| Cash And Short Term Investments | 118.3 M |
Additional Tools for Kalaris Stock Analysis
When running Kalaris Therapeutics' price analysis, check to measure Kalaris Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kalaris Therapeutics is operating at the current time. Most of Kalaris Therapeutics' value examination focuses on studying past and present price action to predict the probability of Kalaris Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kalaris Therapeutics' price. Additionally, you may evaluate how the addition of Kalaris Therapeutics to your portfolios can decrease your overall portfolio volatility.